32 
1 and which will make recommer.dafiun* to tbc Secretary for 
2 the effective admini-trntion of thi* part. 
3 “ (b) The advisory committee sh*U consist of fifteen 
4 members appointed by the Secretary from individuals who 
5 by virtue of their training or experience are nualified to par- 
6 ticipate in the functions of the advisory committee. The mem- 
7 bership of the advisory committee shall include indi viJuals who 
8 are representative of the various scientific and medical dis- 
9 ciplires concerned with recombinant DXA activities and tlie 
10 potential risks to health aud the environment presented by 
11 such activities. Of the individual* appointed as members of 
12 the advisor}' committee, at least two shell have backgrounds 
13 in the ethical oouccras involved in biomedical research, at 
14 least three shall represent the interests of the general public, 
15 and at least eight shall be individuals who are net engaged 
16 in any recombinant DXA activity and do not have a financial 
17 interest in any person engaged in such an activity. The term 
18 of office of a member of the advisory committee shall be three 
19 years, except that of the member? first appointed to the ad- 
20 visor}' committee, five shall be appointed for a term of one 
21 year and fi\c shall be appointed for a term of two years, as 
22 designated by the Secretary at the time of appointment. Sec- 
23 tion 14 of the Federal Vdvi«ory Committee Act shall not 
24 apply with respect to the duration or die advisory committee. 
25 “(c) Members of the advisory committee (other than 
[ 609 ] 
